Labcorp (LH)CEO sold ~$1.5M
Adam H Schechter, CEO at Labcorp, sold ~$1.5M of Labcorp shares.
- ~$1.5M
- Approx. value · 5,903 sh @ $254.50
- 107K
- Holds after · shares reported
- Traded
- May 11, 2026
- Filed
- May 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026Insider · 2 peopleInsiders: 2 sales (~$660K)
- Mar 27, 2026CongressDisclosed purchase of LH — reported range $1,001 - $15,000
- Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
- May 11, 2026 · this disclosureInsiderCEO sold ~$1.5M of LH shares in the open market
What came next
- Jun 8, 2026InsiderOfficer sold ~$201K of LH shares in the open market
- Jul 2, 2026Insider · 2 peopleInsiders: 2 sales (~$93K)
- Jul 30, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 3, 2026Insider · 1 personInsiders: 2 sales (~$439K)
- Aug 4, 2026InsiderOfficer sold ~$283K of LH shares in the open market
- Aug 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 11, 2026, Megan D. Bailey notified Labcorp Holdings Inc. (the “Company”) of her decision to resign as Executive Vice President and President, Central Laboratories and International of the Company, effective September 4, 2026.”
- Aug 11, 2026InsiderCEO sold ~$1.5M of LH shares in the open market
- Aug 17, 2026InsiderDirector sold ~$954K of LH shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Labcorp
For Labcorp, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 13 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.
Other recent filings by Adam H Schechter, President & CEO
- SEC Form 4 at Labcorp (LH)Aug 12, 2026
- SEC Form 4 at Labcorp (LH)Mar 5, 2026
- SEC Form 4 at Labcorp (LH)Feb 13, 2026
- SEC Form 4 at Labcorp (LH)Nov 13, 2025
- SEC Form 4 at Labcorp (LH)Aug 13, 2025
The full history of Adam H Schechter, President & CEO is on the profile page.
How this filing works
Other disclosures at Labcorp
- House Clerk periodic transaction reportSep 9, 2026
- House Clerk periodic transaction reportSep 9, 2026
- House Clerk periodic transaction reportSep 9, 2026
- House Clerk periodic transaction reportSep 9, 2026
- SEC Form 4Aug 18, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its LH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
